$CLRO
CLEARONE INC

2023 Q3 Form 10-Q Financial Statement

#000175392623001034 Filed on August 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022
Revenue $4.889M $5.483M $25.21M
YoY Change -21.95% -25.65% -12.99%
Cost Of Revenue $3.273M $3.635M $15.75M
YoY Change -11.4% -20.42% -7.64%
Gross Profit $1.616M $1.848M $9.457M
YoY Change -37.12% -34.16% -20.64%
Gross Profit Margin 33.05% 33.7% 37.52%
Selling, General & Admin $2.216M $2.330M $12.29M
YoY Change -21.53% -28.94% -9.75%
% of Gross Profit 137.13% 126.08% 129.95%
Research & Development $889.0K $873.0K $4.390M
YoY Change 1.48% -25.83% -24.23%
% of Gross Profit 55.01% 47.24% 46.42%
Depreciation & Amortization $260.0K $228.0K $263.0K
YoY Change -67.38% -71.46% -30.42%
% of Gross Profit 16.09% 12.34% 2.78%
Operating Expenses $3.105M $3.203M $16.68M
YoY Change -16.08% -28.12% -14.07%
Operating Profit -$1.489M -$1.355M -$7.222M
YoY Change 31.77% -17.83% -3.64%
Interest Expense $86.00K -$91.00K $420.0K
YoY Change -4.44% -196.81% -18.29%
% of Operating Profit
Other Income/Expense, Net $243.0K $437.0K $35.10M
YoY Change -8200.0% -70.96% 109593.75%
Pretax Income -$1.332M -$1.009M $27.46M
YoY Change 8.91% 323.95% -444.24%
Income Tax $19.00K $10.00K $6.904M
% Of Pretax Income 25.14%
Net Earnings -$1.351M -$1.019M $20.56M
YoY Change 8.25% 296.5% -367.17%
Net Earnings / Revenue -27.63% -18.58% 81.56%
Basic Earnings Per Share -$0.06 -$0.04 $0.86
Diluted Earnings Per Share -$0.06 -$0.04 $0.83
COMMON SHARES
Basic Shares Outstanding 23.96M shares 23.96M shares 23.94M shares
Diluted Shares Outstanding 23.96M shares 23.96M shares 25.19M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $19.98M $21.49M $984.0K
YoY Change 1277.59% 1686.7% -65.61%
Cash & Equivalents $13.69M $15.09M $984.0K
Short-Term Investments $6.281M $6.408M $0.00
Other Short-Term Assets $3.780M $4.273M $7.808M
YoY Change 91.88% 46.14% 94.18%
Inventory $8.664M $7.547M $8.961M
Prepaid Expenses
Receivables $3.874M $4.232M $3.603M
Other Receivables $6.390M $6.381M $56.07M
Total Short-Term Assets $42.09M $43.93M $77.43M
YoY Change 69.8% 71.38% 162.99%
LONG-TERM ASSETS
Property, Plant & Equipment $590.0K $1.785M $1.430M
YoY Change 6.88% 190.72% -37.31%
Goodwill
YoY Change
Intangibles $1.794M $1.903M
YoY Change -92.46% -92.17%
Long-Term Investments $580.0K $586.0K $0.00
YoY Change -100.0%
Other Assets $112.0K $3.475M $2.822M
YoY Change -97.56% -24.32% -65.43%
Total Long-Term Assets $7.030M $7.749M $6.323M
YoY Change -78.68% -77.02% -82.8%
TOTAL ASSETS
Total Short-Term Assets $42.09M $43.93M $77.43M
Total Long-Term Assets $7.030M $7.749M $6.323M
Total Assets $49.12M $51.68M $83.75M
YoY Change -14.96% -12.93% 26.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.759M $2.435M $1.284M
YoY Change -14.28% 18.95% -76.17%
Accrued Expenses $2.340M $2.587M $3.041M
YoY Change -5.53% 0.66% 19.3%
Deferred Revenue $38.00K $52.00K
YoY Change -47.95% 20.93%
Short-Term Debt $1.204M $1.380M $1.812M
YoY Change 40.82% 70.37% -34.37%
Long-Term Debt Due $1.200M $1.380M $1.920M
YoY Change 40.35% 70.37% 166.67%
Total Short-Term Liabilities $5.341M $6.454M $8.120M
YoY Change -2.13% 17.99% -29.22%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Other Long-Term Liabilities $1.008M $1.856M $1.500M
YoY Change 53.89% 183.36% -10.77%
Total Long-Term Liabilities $1.008M $1.856M $1.500M
YoY Change -39.39% 0.92% -53.36%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.341M $6.454M $8.120M
Total Long-Term Liabilities $1.008M $1.856M $1.500M
Total Liabilities $7.104M $8.310M $9.620M
YoY Change -7.49% 3.54% -34.5%
SHAREHOLDERS EQUITY
Retained Earnings -$3.718M -$2.367M
YoY Change -84.85% -89.84%
Common Stock $46.04M $46.00M
YoY Change -38.54% -38.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $42.01M $43.37M $74.13M
YoY Change
Total Liabilities & Shareholders Equity $49.12M $51.68M $83.75M
YoY Change -14.96% -12.93% 26.53%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022
OPERATING ACTIVITIES
Net Income -$1.351M -$1.019M $20.56M
YoY Change 8.25% 296.5% -367.17%
Depreciation, Depletion And Amortization $260.0K $228.0K $263.0K
YoY Change -67.38% -71.46% -30.42%
Cash From Operating Activities -$1.780M -$7.401M -$4.179M
YoY Change -381.65% 348.82% -4.89%
INVESTING ACTIVITIES
Capital Expenditures $70.00K $336.0K $51.00K
YoY Change -294.44% 8300.0% -76.92%
Acquisitions
YoY Change
Other Investing Activities $690.0K -$6.988M $2.273M
YoY Change -575.86% -1162.01% -128.43%
Cash From Investing Activities $610.0K -$7.324M $2.085M
YoY Change -437.02% -1206.34% -124.51%
FINANCING ACTIVITIES
Cash Dividend Paid $28.98M $0.00
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $720.0K
YoY Change -34.43%
Cash From Financing Activities -220.0K -29.20M $2.051M
YoY Change 22.91% -3853.6% -79.9%
NET CHANGE
Cash From Operating Activities -1.780M -7.401M -$4.179M
Cash From Investing Activities 610.0K -7.324M $2.085M
Cash From Financing Activities -220.0K -29.20M $2.051M
Net Change In Cash -1.390M -43.93M -$87.00K
YoY Change -611.03% 20918.18% -96.77%
FREE CASH FLOW
Cash From Operating Activities -$1.780M -$7.401M -$4.179M
Capital Expenditures $70.00K $336.0K $51.00K
Free Cash Flow -$1.850M -$7.737M -$4.230M
YoY Change -376.95% 368.06% -8.34%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1071000 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
24000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
437000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1019000 usd
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
2807000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1851000 usd
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6287019 shares
clro Gain Loss On Debt Forgiven
GainLossOnDebtForgiven
0 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23948631 shares
dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
7375000 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23923110 shares
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Registrant Name
EntityRegistrantName
CLEARONE INC
dei Entity Central Index Key
EntityCentralIndexKey
0000840715
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33660
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0398877
dei Entity Address Address Line1
EntityAddressAddressLine1
5225 Wiley Post Way, Suite 500
dei Entity Address City Or Town
EntityAddressCityOrTown
Salt Lake City
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84116
dei City Area Code
CityAreaCode
(801)
dei Local Phone Number
LocalPhoneNumber
975-7200
dei Security12b Title
Security12bTitle
Common Stock, $0.001
dei Trading Symbol
TradingSymbol
CLRO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
23958979 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15086000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
984000 usd
CY2023Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
6408000 usd
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
0 usd
CY2023Q2 clro Receivables Legal Settlement
ReceivablesLegalSettlement
0 usd
CY2022Q4 clro Receivables Legal Settlement
ReceivablesLegalSettlement
55000000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
326000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
326000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4232000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3603000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
7547000 usd
CY2023Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
6381000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4273000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7808000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
43927000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
77427000 usd
CY2023Q2 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
586000 usd
CY2022Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
0 usd
CY2023Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
3361000 usd
CY2022Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
2707000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
614000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
383000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1047000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1903000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2071000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
114000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
115000 usd
CY2023Q2 us-gaap Assets
Assets
51676000 usd
CY2022Q4 us-gaap Assets
Assets
83750000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2435000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1284000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2587000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3041000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
52000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
63000 usd
CY2023Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
1380000 usd
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
3732000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
6454000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8120000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
848000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
492000 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1008000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1008000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
8310000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
9620000 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23958979 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23958979 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23955767 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23955767 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
24000 usd
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
45979000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
74910000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-270000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-288000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-516000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
43366000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
74130000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
51676000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
83750000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5483000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
7375000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
9661000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
14920000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3635000 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4568000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6498000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9297000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
1848000 usd
us-gaap Gross Profit
GrossProfit
3163000 usd
us-gaap Gross Profit
GrossProfit
5623000 usd
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1323000 usd
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1562000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2515000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3122000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
873000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1177000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1916000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2530000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1007000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1717000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2276000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3473000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
3203000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
4456000 usd
us-gaap Operating Expenses
OperatingExpenses
6707000 usd
us-gaap Operating Expenses
OperatingExpenses
9125000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1355000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1649000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3544000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3502000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
91000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
94000 usd
us-gaap Interest Expense
InterestExpense
383000 usd
us-gaap Interest Expense
InterestExpense
195000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1505000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2103000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1508000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1009000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-238000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1824000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2189000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
35000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1851000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2224000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23955802 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23948631 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23955785 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23923110 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23955802 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23948631 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23955785 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23923110 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1019000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-257000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2224000 usd
CY2023Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
14000 usd
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
26000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2000 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1000 usd
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-12000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
4000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-23000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1006000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-243000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1833000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2249000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1851000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2224000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
449000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1593000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
217000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
300000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
47000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
65000 usd
us-gaap Inventory Write Down
InventoryWriteDown
103000 usd
us-gaap Inventory Write Down
InventoryWriteDown
27000 usd
clro Gain Loss On Debt Forgiven
GainLossOnDebtForgiven
1528000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
629000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-879000 usd
clro Increase Decrease In Legal Settlement Receivables
IncreaseDecreaseInLegalSettlementReceivables
-55000000 usd
clro Increase Decrease In Legal Settlement Receivables
IncreaseDecreaseInLegalSettlementReceivables
0 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-657000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-730000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3536000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1097000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1151000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3341000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-204000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
33000 usd
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-5310000 usd
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
0 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-11000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-11000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-235000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-312000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
52920000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2692000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
326000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
79000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
58000 usd
clro Capitalized Patent Defense Costs
CapitalizedPatentDefenseCosts
0 usd
clro Capitalized Patent Defense Costs
CapitalizedPatentDefenseCosts
497000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
2344000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
3008000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
9332000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7393000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2437000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
28979000 usd
CY2022 us-gaap Payments Of Dividends
PaymentsOfDividends
0 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
2000 usd
clro Proceeds From Debt Refund Upon Full Forgiveness
ProceedsFromDebtRefundUponFullForgiveness
0 usd
clro Proceeds From Debt Refund Upon Full Forgiveness
ProceedsFromDebtRefundUponFullForgiveness
768000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
2450000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
360000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-31428000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
410000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-23000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
14102000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
132000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
984000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1071000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15086000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1203000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
6631000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
39000 usd
us-gaap Interest Paid Net
InterestPaidNet
273000 usd
us-gaap Interest Paid Net
InterestPaidNet
97000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15086000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
984000 usd
CY2023Q2 clro Working Capital Deficit
WorkingCapitalDeficit
37473000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
52920000 usd
clro Increase Decrease In Net Cash Provided By Used In Operating Activities
IncreaseDecreaseInNetCashProvidedByUsedInOperatingActivities
55612000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2692000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5483000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
7375000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
9661000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
14920000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5483000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
9661000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
14920000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1019000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-257000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1851000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2224000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23955802 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23955785 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23923110 shares
CY2022Q2 us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
0 shares
us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
0 shares
us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
0 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23955802 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23948631 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23955785 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2023Q2 clro Incremental Common Shares Attributable To Dilutive Effect Of Weighted Average Options Warrants And Convertible Portion Of Senior Convertible Notes Outstanding
IncrementalCommonSharesAttributableToDilutiveEffectOfWeightedAverageOptionsWarrantsAndConvertiblePortionOfSeniorConvertibleNotesOutstanding
6287019 shares
CY2022Q2 clro Incremental Common Shares Attributable To Dilutive Effect Of Weighted Average Options Warrants And Convertible Portion Of Senior Convertible Notes Outstanding
IncrementalCommonSharesAttributableToDilutiveEffectOfWeightedAverageOptionsWarrantsAndConvertiblePortionOfSeniorConvertibleNotesOutstanding
6937350 shares
clro Incremental Common Shares Attributable To Dilutive Effect Of Weighted Average Options Warrants And Convertible Portion Of Senior Convertible Notes Outstanding
IncrementalCommonSharesAttributableToDilutiveEffectOfWeightedAverageOptionsWarrantsAndConvertiblePortionOfSeniorConvertibleNotesOutstanding
6327495 shares
clro Incremental Common Shares Attributable To Dilutive Effect Of Weighted Average Options Warrants And Convertible Portion Of Senior Convertible Notes Outstanding
IncrementalCommonSharesAttributableToDilutiveEffectOfWeightedAverageOptionsWarrantsAndConvertiblePortionOfSeniorConvertibleNotesOutstanding
6999665 shares
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6937350 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6327495 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6999665 shares
CY2023Q2 clro Available For Sale Marketable Securities Amortized Cost
AvailableForSaleMarketableSecuritiesAmortizedCost
6979000 usd
CY2023Q2 clro Available For Sale Marketable Securities Accumulated Gross Unrealized Gain
AvailableForSaleMarketableSecuritiesAccumulatedGrossUnrealizedGain
22000 usd
CY2023Q2 clro Available For Sale Marketable Securities Accumulated Gross Unrealized Loss
AvailableForSaleMarketableSecuritiesAccumulatedGrossUnrealizedLoss
7000 usd
CY2023Q2 us-gaap Marketable Securities
MarketableSecurities
6994000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
6396000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
6408000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
583000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
586000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
0 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
0 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
6979000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
6994000 usd
CY2023Q2 clro Marketable Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Fair Value
MarketableSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsFairValue
2138000 usd
CY2023Q2 clro Marketable Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
MarketableSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
-7000 usd
CY2023Q2 clro Marketable Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Fair Value
MarketableSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerFairValue
0 usd
CY2023Q2 clro Marketable Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
MarketableSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0 usd
CY2023Q2 clro Marketable Securities Available For Sale Unrealized Loss Position Fair Value
MarketableSecuritiesAvailableForSaleUnrealizedLossPositionFairValue
2138000 usd
CY2023Q2 clro Marketable Securities Available For Sale Unrealized Loss Position Accumulated Loss
MarketableSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
-7000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
10991000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
10912000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9088000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8841000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1903000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2071000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
129000 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
682000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
247000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1352000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
269000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
253000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
192000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
191000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
61000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
937000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1903000 usd
CY2023Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
3388000 usd
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
4499000 usd
CY2023Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4159000 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4462000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
7547000 usd
CY2023Q2 clro Inventory Noncurrent Raw Materials Net Of Reserves
InventoryNoncurrentRawMaterialsNetOfReserves
1551000 usd
CY2022Q4 clro Inventory Noncurrent Raw Materials Net Of Reserves
InventoryNoncurrentRawMaterialsNetOfReserves
1068000 usd
CY2023Q2 clro Inventory Noncurrent Finished Goods Net Of Reserves
InventoryNoncurrentFinishedGoodsNetOfReserves
1810000 usd
CY2022Q4 clro Inventory Noncurrent Finished Goods Net Of Reserves
InventoryNoncurrentFinishedGoodsNetOfReserves
1639000 usd
CY2023Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
3361000 usd
CY2022Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
2707000 usd
CY2023Q2 us-gaap Inventory Write Down
InventoryWriteDown
80000 usd
CY2022Q2 us-gaap Inventory Write Down
InventoryWriteDown
27000 usd
us-gaap Inventory Write Down
InventoryWriteDown
103000 usd
us-gaap Inventory Write Down
InventoryWriteDown
27000 usd
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
110000 usd
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
170000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
259000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
349000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
264000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
356000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
341000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1171000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1047000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
391000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
641000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
492000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1239000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1133000 usd
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y8M26D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y1M13D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.064 pure
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0593 pure
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
228000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
439000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
272000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
210000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
216000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
37000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1402000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
163000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1239000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
43366000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
51323000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
43366000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
51323000 usd
CY2023Q2 clro Warrants Carrying Amount
WarrantsCarryingAmount
318000 usd
CY2022Q4 clro Warrants Carrying Amount
WarrantsCarryingAmount
318000 usd
CY2023Q2 clro Warrant Instrument Convertible Beneficial Conversion Feature
WarrantInstrumentConvertibleBeneficialConversionFeature
122000 usd
CY2022Q4 clro Warrant Instrument Convertible Beneficial Conversion Feature
WarrantInstrumentConvertibleBeneficialConversionFeature
122000 usd
CY2023Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
440000 usd
CY2022Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
440000 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
1470000 usd
CY2023Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1470000 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P6Y
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
160000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0391 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.9147 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
488477 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.48
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
160000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1355 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.5
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
1437 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
8.88
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
645685 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.14
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
405400 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.3
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Nonvested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested
221000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
24000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
30000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
47000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
65000 usd
CY2023Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
962000 usd
CY2023Q2 us-gaap Marketable Securities
MarketableSecurities
6994000 usd
CY2022Q4 us-gaap Marketable Securities
MarketableSecurities
0 usd

Files In Submission

Name View Source Status
0001753926-23-001034-index-headers.html Edgar Link pending
0001753926-23-001034-index.html Edgar Link pending
0001753926-23-001034.txt Edgar Link pending
0001753926-23-001034-xbrl.zip Edgar Link pending
clro-20230630.htm Edgar Link pending
clro-20230630.xsd Edgar Link pending
ex311_1.htm Edgar Link pending
ex312_2.htm Edgar Link pending
ex321_3.htm Edgar Link pending
ex322_4.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
clro-20230630_cal.xml Edgar Link unprocessable
clro-20230630_def.xml Edgar Link unprocessable
clro-20230630_lab.xml Edgar Link unprocessable
clro-20230630_pre.xml Edgar Link unprocessable
clro-20230630_htm.xml Edgar Link completed
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable